Sanger spinout gets $10M, tackles the microbiome frontier; Adaptimmune and Bellicum partner T cell tech
The Sanger Institute has launched a new spinout dubbed Microbiotica, which is leaping into the hot microbiome field. The IP Group and Cambridge Innovation Capital are bankrolling the startup with $10 million and what’s billed as “one of the world’s most extensive collections of cultured human gut bacteria with associated genome analysis, along with humanized models for the development of therapeutics based on live bacteria.” Microbiotica plans to establish labs within the Wellcome Genome Campus at Hinxton, Cambridge.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
